The European Medicines Agency’s request to make all clinical trial data available is key to countering bias in publication, drug prescription practice and health policy. Continue reading
The European Medicines Agency’s request to make all clinical trial data available is key to countering bias in publication, drug prescription practice and health policy. Continue reading →
Posted in Biotechnology, Development, Medicine, Methodology, Risk assessment
Tagged clinical research, medical research